Serine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: Synthesis and interaction with hPEPT1

Molecular Pharmaceutics

Volumn 7, Issue 6, 2010, Pages 2349-2361

  Peterson, Larryn W ^a   Sala Rabanal, Monica ^b,c   Krylov, Ivan S ^a   Serpi, Michaela ^a   Kashemirov, Boris A ^a   McKenna, Charles E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; ACICLOVIR; CIDOFOVIR; PEPTIDE TRANSPORTER 1; VALACICLOVIR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG PROTEIN BINDING; DRUG SYNTHESIS; DRUG TRANSPORT; ESTERIFICATION; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; XENOPUS LAEVIS;

ADENINE; CYTOSINE; DIPEPTIDES; HUMANS; MOLECULAR STRUCTURE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; PRODRUGS; SERINE; STEREOISOMERISM; SYMPORTERS;

EID: 78649962839     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp100186b     Document Type: Article

References (27)

1. De Clercq, E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections Clin. Microbiol. Rev. 2003, 16 (4) 569-596 (Pubitemid 37296550)
2. Peterson, L. W.; McKenna, C. E. Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues Expert Opin. Drug Delivery 2009, 6 (4) 405-420
3. Hostetler, K. Y. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art Antiviral Res. 2009, 82 (2) A84-A98
4. Eriksson, U.; Peterson, L. W.; Kashemirov, B. A.; Hilfinger, J. M.; Drach, J. C.; Borysko, K. Z.; Breitenbach, J. M.; Kim, J. S.; Mitchell, S.; Kijek, P.; McKenna, C. E. Serine peptide phosphoester prodrugs of cyclic cidofovir: Synthesis, transport, and antiviral activity Mol. Pharmaceutics 2008, 5 (4) 598-609
5. McKenna, C. E.; Kashemirov, B. A.; Eriksson, U.; Amidon, G. L.; Kish, P. E.; Mitchell, S.; Kim, J.-S.; Hilfinger, J. M. Cidofovir peptide conjugates as prodrugs J. Organomet. Chem. 2005, 690 (10) 2673-2678
6. Mendel, D. B.; Cihlar, T.; Moon, K.; Chen, M. S. Conversion of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine to cidofovir by an intracellular cyclic CMP phosphodiesterase Antimicrob. Agents Chemother. 1997, 41 (3) 641-646
7. Anastasi, C.; Quelever, G.; Burlet, S.; Garino, C.; Souard, F.; Kraus, J.-L. New antiviral nucleoside prodrugs await application Curr. Med. Chem. 2003, 10 (18) 1825-1843
8. Ariza, M. E. Current prodrug strategies for the delivery of nucleotides into cells Drug Des. Rev.-Online 2005, 2 (5) 373-387
9. Balimane, P. V.; Tamai, I.; Guo, A.; Nakanishi, T.; Kitada, H.; Leibach, F. H.; Tsuji, A.; Sinko, P. J. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir Biochem. Biophys. Res. Commun. 1998, 250 (2) 246-51
10. Guo, A.; Hu, P.; Balimane, P. V.; Leibach, F. H.; Sinko, P. J. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line J. Pharmacol. Exp. Ther. 1999, 289 (1) 448-54
11. Han, H.-K.; De Vrueh, R. L. A.; Rhie, J. K.; Covitz, K.-M. Y.; Smith, P. L.; Lee, C.-P.; Oh, D.-M.; Sadee, W.; Amidon, G. L. 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter Pharm. Res. 1998, 15 (8) 1154-1159
12. Beauchamp, L. M.; Orr, G. F.; De Miranda, P.; Burnette, T.; Krenitsky, T. A. Amino acid ester prodrugs of acyclovir Antiviral Chem. Chemother. 1992, 3 (3) 157-164
13. Sala-Rabanal, M.; Loo, D. D. F.; Hirayama, B. A.; Turk, E.; Wright, E. M. Molecular interactions between dipeptides, drugs and the human intestinal H+-oligopeptide cotransporter hPEPT1 J. Physiol. 2006, 574 (1) 149-166
14. Kottra, G.; Frey, I.; Daniel, H. Inhibition of intracellular dipeptide hydrolysis uncovers large outward transport currents of the peptide transporter PEPT1 in Xenopus oocytes Pfluegers Arch.: Eur. J. Physiol. 2009, 457 (4) 809-820
15. Larsen, S. B.; Jorgensen, F. S.; Olsen, L. QSAR models for the human H+/peptide symporter, hPEPT1: Affinity prediction using alignment-independent descriptors J. Chem. Inf. Model. 2008, 48 (1) 233-241
16. Winiwarter, S.; Hilgendorf, C. Modeling of drug-transporter interactions using structural information Curr. Opin. Drug Discovery 2008, 11 (1) 95-103
17. Pedretti, A.; De Luca, L.; Marconi, C.; Negrisoli, G.; Aldini, G.; Vistoli, G. Modeling of the intestinal peptide transporter hPepT1 and analysis of its transport capacities by docking and pharmacophore mapping ChemMedChem 2008, 3 (12) 1913-1921
18. Foley, D.; Pieri, M.; Pettecrew, R.; Price, R.; Miles, S.; Lam, H. K.; Bailey, P.; Meredith, D. The in vitro transport of model thiodipeptide prodrugs designed to target the intestinal oligopeptide transporter, PepT1 Org. Biomol. Chem. 2009, 7 (18) 3652-3656
19. Nashed, Y. E.; Mitra, A. K. Synthesis and characterization of novel dipeptide ester prodrugs of acyclovir Spectrochim. Acta, Part A 2003, 59A (9) 2033-2039
20. Mackenzie, B.; Loo, D. D.; Fei, Y.; Liu, W. J.; Ganapathy, V.; Leibach, F. H.; Wright, E. M. Mechanisms of the human intestinal H+-coupled oligopeptide transporter hPEPT1 J. Biol. Chem. 1996, 271 (10) 5430-5437
21. Krylov, I. S.; Peterson, L. W.; Kashemirov, B. A.; Breitenbach, J.; Borysco, K.; Drach, J. C.; Kim, J. S.; Hilfinger, J. M.; McKenna, C. E. In vitro transport, activation and antiviral evaluation of new HPMPA prodrugs synthesized on a solid support Antiviral Res. 2009, 82 (2) A75
22. Liang, R.; Fei, Y. J.; Prasad, P. D.; Ramamoorthy, S.; Han, H.; Yangfeng, T. L.; Hediger, M. A.; Ganapathy, V.; Leibach, F. H. Human intestinal H+/peptide cotransporter-cloning, functional expression, and chromosomal localization J. Biol. Chem. 1995, 270 (12) 6456-6463
23. Rubio-Aliaga, I.; Daniel, H. Peptide transporters and their roles in physiological processes and drug disposition Xenobiotica 2008, 38 (7-8) 1022-1042
24. Talluri, R. S.; Samanta, S. K.; Gaudana, R.; Mitra, A. K. Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir Int. J. Pharm. 2008, 361 (1-2) 118-124
25. Loo, D. D. F.; Hirayama, B. A.; Sala-Rabanal, M.; Wright, E. M. How Drugs Interact with Transporters: SGLT1 as a Model J. Membr. Biol. 2008, 223 (2) 87-106
26. Sala-Rabanal, M.; Loo, D. D. F.; Hirayama, B. A.; Wright, E. M. Molecular mechanism of dipeptide and drug transport by the human renal H+/oligopeptide cotransporter hPEPT2 Am. J. Physiol. 2008, 294 (6, Pt.2) F1422-F1432
27. Dressman, J. B.; Thelen, K.; Jantratid, E. Towards quantitative prediction of oral drug absorption Clin. Pharmacokinet. 2008, 47 (10) 655-667